DB증권
016610KOSPI금융 지원 서비스업63.4 / 100
Reference Date: 2026-07-24
Company InformationBased on 2025 Annual Report
Business Overview
DB Securities reported a 77% increase in pre-tax profit and an 88% rise in net income (excluding non-controlling interests) to 1.169 trillion won and 814 billion won, respectively, in 2025. Growth was driven by increased commission income and financial product evaluation gains across key segments like Wealth Management, Corporate Finance, and S&T, alongside contributions from asset management and savings bank operations.
Number of Employees
782people
Average Salary
135.0M KRW
Score Calculation Basis
Detailed Financial Score
Half of industry avg (excellent)
Half of industry avg (excellent)
4.2x industry avg (excellent)
61.6x industry avg (risky)
Avg ▲27.5% (2-year basis)
Avg ▲139.6% (2-year basis)
Avg ROE 4.5% (improving, 3yr)
Detailed News Sentiment
- Neutral'하루 7조' 삼전·닉스 레버리지 왝더독… 당국 보완책 '시차'에 혼란...
Market volatility impacts DB증권 indirectly due to broader regulatory changes affecting stock market conditions.
- Positive파마리서치, 2분기 실적 기대에 10%대 급등…증권가 "의료기기·화장품...
파마리서치의 의료기기와 화장품 부문 실적 기대가 급등하며 긍정적인 시장 반응을 이끌고 있다.
- Positive[바이오사 리포트] 삼성바이오, 반기 영업익 첫 '1조'…파업부담 이연
삼성바이오로직스의 반기 영업익이 1조원을 돌파하며 긍정적인 실적을 보였으나, 파업 부담으로 인해 영업이익은 기대치에 미치지 못했다.
Detailed Momentum
Near 52w low (9%, downtrend)
1m -1.19% (flat)
Volume flat
Detailed Disclosure
- Neutral일괄신고추가서류(기타파생결합사채)2026-07-22
- Neutral일괄신고추가서류(파생결합사채-주가연계파생결합사채)2026-07-22
- Neutral투자설명서(일괄신고)2026-07-22
- Neutral일괄신고추가서류(파생결합사채-주가연계파생결합사채)2026-07-22
- Neutral일괄신고추가서류(기타파생결합사채)2026-07-22
